The Effect of Rectal and Sublingual Misoprostol Administration in Postpartum or Intrapartum Haemorrhage at Elective Caesarean Delivery: a... | NCT01931410 | Trialant
CompletedInterventionalPhase 4Updated Feb 25, 2014
The Effect of Rectal and Sublingual Misoprostol Administration in Postpartum or Intrapartum Haemorrhage at Elective Caesarean Delivery: a Randomized Controlled Trial
ClinicalTrials.gov ID
NCT01931410
Lead Sponsor
Istanbul Bakirkoy Maternity and Children Diseases HospitalOTHER_GOV
Overall Status
Completed
Study Type
Interventional
Phase
Phase 4
Enrollment
618Actual
Last Update Posted
Feb 25, 2014Estimated
Start Date
Jun 2013
Primary Completion Date
Jan 2014Actual
Completion Date
Feb 2014Actual
Brief Summary
The investigators hypothesis in this study is that administration of rectal and sublingual misoprostol decreases intrapartum and postpartum haemorrhage.
ıntrapartum Haemorrhage
Postpartum Haemorrhage
Misoprostol
Ages Eligible for Study
Adult (18-64)
Sexes Eligible for Study
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
live and singleton pregnancy
Elective caesarean
Gestational week greater than 37 weeks
patient between 18-44 year old
Exclusion Criteria:
-multiple pregnancy
Preeclampsia
Gestational diabetes
Macrosomia
Oligohidraamnıos
Polihidraamnıos
Myoma
Morbid obesity
Coagulatıon defect (such as HELLP syndrome)
Primary Purpose
Prevention
Allocation
Randomized
Interventional Model
Crossover Assignment
Masking
Double
No central contacts
There are no central contacts for this study.
No locations
There are no locations for this study.
Lead Sponsor
Istanbul Bakirkoy Maternity and Children Diseases HospitalOTHER_GOV